Evidence map›Paper›PMID 39766207›Full record

ArticleBiomolecules2024

XModNN: Explainable Modular Neural Network to Identify Clinical Parameters and Disease Biomarkers in Transcriptomic Datasets.

Jan Oldenburg, Jonas Wagner, Sascha Troschke-Meurer, Jessica Plietz, Lars Kaderali, Henry Völzke, Matthias Nauck, Georg Homuth, Uwe Völker, Stefan Simm

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Pathway-guided architectures for interpretable AI in biological research.Computational and structural biotechnology journal · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jan OldenburgInstitute of Bioinformatics, University Medicine Greifswald, 17475 Greifswald, Germany.
Jonas WagnerInstitute of Bioinformatics, University Medicine Greifswald, 17475 Greifswald, Germany.
Sascha Troschke-MeurerInstitute for Pediatric Hematology and Oncology, University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-6185-462X
Jessica PlietzInstitute for Pediatric Hematology and Oncology, University Medicine Greifswald, 17475 Greifswald, Germany.
Lars KaderaliInstitute of Bioinformatics, University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-2359-2294
Henry VölzkeInstitute for Community Medicine, University Medicine Greifswald, 17475 Greifswald, Germany.
Matthias NauckInstitute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-6678-7964
Georg HomuthInterfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 17475 Greifswald, Germany.
Uwe VölkerInterfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-5689-3448
Stefan SimmInstitute of Bioinformatics, University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0000-0001-9371-2709

Funding

Deutsches Zentrum für Luft- und Raumfahrt e. V. (DLR) 50WK2270I
6 · The paper itself

Abstract

The Explainable Modular Neural Network (XModNN) enables the identification of biomarkers, facilitating the classification of diseases and clinical parameters in transcriptomic datasets. The modules within XModNN represent specific pathways or genes of a functional hierarchy. The incorporation of biological insights into the architectural design reduced the number of parameters. This is further reinforced by the weighted multi-loss progressive training, which enables successful classification with a reduced number of replicates. The combination of this workflow with layer-wise relevance propagation ensures a robust post hoc explanation of the individual module contribution. Two use cases were employed to predict sex and neuroblastoma cell states, demonstrating that XModNN, in contrast to standard statistical approaches, results in a reduced number of candidate biomarkers. Moreover, the architecture enables the training on a limited number of examples, attaining the same performance and robustness as support vector machine and random forests. The integrated pathway relevance analysis improves a standard gene set overrepresentation analysis, which relies solely on gene assignment. Two crucial genes and three pathways were identified for sex classification, while 26 genes and six pathways are highly important to discriminate adrenergic-mesenchymal cell states in neuroblastoma cancer.

Indexed as

Biomarkers, TumorNeural Networks, ComputerNeuroblastomaTranscriptomeBiomarkersDatabases, GeneticFemaleGene Expression ProfilingHumansMaleSupport Vector MachineBiomarkersBiomarkers, Tumorbiomarker detectionexplainable AImodular neural networknext-generation sequencing

Identifiers

PMID39766207
PMCPMC11673716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.